18 hasil untuk "Smith-Cohn, Matthew"
Menampilkan 1–18 · 1,06 detik · RSS
-
Artikel Jurnal Teks lengkap
NI-70 STEREOTACTIC BIOPSY WITH AND WITHOUT INTRAOPERATIVE MRI
BACKGROUND: Intraoperative magnetic imaging (iMRI) has been described as a useful adjunct for stereotactic brain biopsy, however, there is limited data demonstrating how this technology performs compared to biopsies done without intraoperative imaging. OBJECTIVE: To compare the results of…
-
Artikel Jurnal Teks lengkap
PATH-54. UTILITY OF NEXT GENERATION SEQUENCING IN ADULT PRIMARY BRAIN TUMORS: IMPACT ON DIAGNOSIS AND PERSONALIZED THERAPY
BACKGROUND: Historically, the molecular characterization of gliomas and other brain tumors has been controversial. A diagnosis was primarily made by histological analysis alone, despite concordance among neuropathologists being as low as 52% in some cases. Based on the 2016 World Health…
-
Artikel Jurnal Teks lengkap
DDRE-49. TRANSIENT OPENING OF THE BLOOD-BRAIN BARRIER BY VASOACTIVE PEPTIDES TO INCREASE CNS DRUG DELIVERY: REALITY VERSUS WISHFUL THINKING?
BACKGROUND: Drug delivery to treat neurologic disease and cancers of the central nervous system (CNS) is severely limited by the blood-brain barrier (BBB). Vasoactive peptides (VAPs) such as regadenoson, adenosine, and labradimil have been shown in animal studies to transiently open the BBB, and…
-
Artikel Jurnal Teks lengkap
TIP-28. Fine-tuning large language models using NCCN guidelines to aid primary CNS cancer treatment decisions
Managing primary central nervous system (CNS) cancers presents a challenge, particularly for Rural or general oncologists (without access to a neuro-oncologist) who do not frequently encounter these conditions. NCCN guidelines continue to change compared to when oncologists were trained, which can…
-
Artikel Jurnal Teks lengkap
Glioma Subclassifications and Their Clinical Significance
The impact of targeted therapies in glioma has been modest. All the therapies that have demonstrated a significant survival benefit for gliomas in Phase III trials, including radiation, chemotherapy (temozolomide and PCV [procarbazine, lomustine, vincristine]), and tumor-treating fields, are based…
-
Artikel Jurnal Teks lengkap
Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases
AIM: Therapeutic targeting of BRAF alterations in primary brain tumor patients has demonstrated clinical activity in case reports and early trials; however, there is limited high-level evidence of the efficacy. PATIENTS & RESULTS: Targeting BRAF V600E mutations with concurrent dabrafenib and…
-
Artikel Jurnal Teks lengkap
Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?
Background: The blood-brain barrier inhibits the central nervous system penetration of 98% of small molecule drugs and virtually all biologic agents, which has limited progress in treating neurologic disease. Vasoactive peptides have been shown in animal studies to transiently disrupt the…
-
Artikel Jurnal Teks lengkap
IT-17 ONO-AE3-208 INHIBITS MYELOID-DERIVED SUPPRESSOR CELLS AND GLIOMA GROWTH
Myeloid-Derived Suppressor Cells (MDSCs) heavily infiltrate in a variety of solid tumors and suppress anti-tumor T-cell activity. Our recent studies have demonstrated the ability of monocytic, Ly6C(+) MDSCs to promote glioma growth through the activation of cyclooxygenase (COX)-2 pathway, which is…
-
Artikel Jurnal Teks lengkap
HOUT-01. A RETROSPECTIVE ANALYSIS OF OUTCOMES WITH TEMOZOLOMIDE AS INITIAL TREATMENT OF GRADE 2 OLIGODENDROGLIOMA
INTRODUCTION: Prior randomized studies have shown a survival benefit of radiation and chemotherapy compared to radiation alone for grade 2 gliomas (astrocytoma and oligodendroglioma) and grade 3 oligodendroglioma. However, data is mixed regarding outcomes for patients treated initially with…
-
Artikel Jurnal Teks lengkap
IT-33 USE OF IFN-ALPHA AND POLY-ICLC AS CHEMOKINE MODULATORS FOR IMMUNOTHERAPY IN GLIOMAS
Chemokines are known to play an integral role in the cellular trafficking of the immune system, which has important implications in immunotherapy of cancers. Expression of CXCL10/IP10 and CCL5/RANTES has been shown to correlate with increased infiltration of effector T cells and natural killer (NK)…
-
Artikel Jurnal Teks lengkap
Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
-
Artikel Jurnal Teks lengkap
IMPS-30 NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION
-
Artikel Jurnal Teks lengkap
IDH‐mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH‐mutant low grade gliomas of the brainstem with several key clinicopathologic and molecular features in common. We discuss these three…
-
Artikel Jurnal Teks lengkap
Molecular clarification of brainstem astroblastoma with EWSR1-BEND2 fusion in a 38-year-old man
The majority of astroblastoma occur in a cerebral location in children and young adults. Here we describe the unusual case of a 38-year-old man found to have a rapidly growing cystic enhancing circumscribed brainstem tumor with high grade histopathology classified as astroblastoma, MN1-altered by…
-
Artikel Jurnal Teks lengkap
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
BACKGROUND: Cognitive impairments are a common burden for patients with primary CNS tumors. Neuropsychological assessment batteries can be too lengthy, which limits their use as an objective measure of cognition during routine care. The purpose of this study was to evaluate the feasibility and…
-
Artikel Jurnal Teks lengkap
INNV-27. AN INNOVATIVE VIRTUAL MULTI-INSTITUTIONAL, MULTIDISCIPLINARY NEURO-ONCOLOGY TUMOR BOARD: THE NIH-NOB EXPERIENCE DURING THE COVID-19 PANDEMIC
BACKGROUND: The American Academy of Neurology Institute and Society for Neuro-Oncology recommend multidisciplinary tumor board (MTB) meetings as a quality metric in neuro-oncology. With the COVID-19 pandemic resulting in travel restrictions, we expanded our existing MTB by transitioning to a…
-
Artikel Jurnal Teks lengkap
PATH-23. CLINICOPATHOLOGIC ANALYSIS OF NOVEL METHYLATION CLUSTERS OF IDH-WILDTYPE DIFFUSE GLIOMAS
Methylation profiling of brain tumors has revealed novel clusters whose biological and clinical significance is unknown. These include three entities termed by the 12.5 version of the Heidelberg methylation classifier as adult-type diffuse high grade glioma, IDH-wildtype, subtype B (HGG_B), subtype…
-
Artikel Jurnal Teks lengkap
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors
PURPOSE: Multidisciplinary tumor boards (MTBs) integrate clinical, molecular, and radiological information and facilitate coordination of neuro-oncology care. During the COVID-19 pandemic, our MTB transitioned to a virtual and multi-institutional format. We hypothesized that this expansion would…